AVP and Sepsis: Hence, the present experimental study investigates whether AVP exerts a potential immunomodulatory effect on PMNs at physiological, pathological (septical), therapeutic (under continuous AVP-infusion administration during sepsis therapy), and supraclinical concentrations and the sole potential effect of chlorobutanol, a common component of the drug AVP, on PMNs.